Acceptable risks : politics, policy, and risky technologies

Heimann, C. F. Larry (Clarence Fredrick)
Ann Arbor : University of Michigan Press, [1997]

Addressing the FDA's performance, efficiency, and use of resources : hearings of the Committee on La

United States. Congress. Senate. Committee on Labor and Human Resources.
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1997.

Advancing the discipline of regulatory science for medical product development : an update on progre

Boname, Morgan L., author.
Washington, DC : National Academies Press, [2016]

Assuring data quality and validity in clinical trials for regulatory decision making : workshop repo

Washington, DC : National Academy Press, [1999]

Building a national framework for the establishment of regulatory science for drug development : wor

Washington, D.C. : National Academies Press, [2011]

By prescription only; a report on the roles of the United States Food and Drug Administration, the A

Mintz, Morton.
Boston : Houghton Mifflin, 1967.
2d ed. rev. and updated.

Compassionate use and emergency use authorization for unapproved drugs : FDA policies and background

New York : Nova Publishers, [2016]

Cosmetics and FDA regulation

New York : Nova Science Publishers, 2013.

Dangerous prescription

[Alexandria, Va.] : PBS DVD Video, [2003]

Development of FDA-regulated medical products : a translational approach

Whitmore, Elaine, author.
Milwaukee, Wisconsin : ASQ Quality Press, 2012.
Second edition.

Dietary supplements : a framework for evaluating safety

Washington, D.C. : National Academies Press, [2005]

Drug compounding : background, issues and FDA oversight

New York : Nova Publishers, [2014]

Enhancing food safety : the role of the Food and Drug Administration

Institute of Medicine (U.S.). Committee on the Review of Food and Drug Administration's Role in Ensuring Safe Food.
Washington, D.C. : National Academies Press, [2010]

The FDA and Generally Recognized as Safe (GRAS) substances

Hauppauge, N.Y. : Nova Science Publishers, [2011]

The FDA and the future of American biomedical and food industries : hearing of the Committee on Labo

United States. Congress. Senate. Committee on Labor and Human Resources.
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1995.

FDA Export Reform and Enhancement Act of 1995 : hearing before the Subcommittee on Aging of the Comm

United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Aging.
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1995.

FDA in the twenty-first century : the challenges of regulating drugs and new technologies

New York : Columbia University Press, [2015]

Food, Drug, Cosmetic, and Device Enforcement Authorities Act : hearing of the Committee on Labor and

United States. Congress. Senate. Committee on Labor and Human Resources.
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1992.

Food issues, policies, and safety considerations.

New York : Nova Science Publishers, Inc., [2016]

Food labeling : FDA protections & country-of-origin labels

New York : Novinka, Nova Science Publishers, Incorporated, [2012]

Food labelling : the FDA's role in the selection of healthy foods

New York : Nova Science Publishers, [2009]

Forbidden cures

Fredman, Steven.
New York : Stein and Day, 1976.

Infant formula : our children need better protection : report together with dissenting views

United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations.
Washington : U.S. Govt. Print. Off. : for sale by the Supt. of Docs., U.S. Govt. Print. Off., 1980.

Integration of FDA and NIOSH processes used to evaluate respiratory protective devices for health ca

Liverman, Catharyn T., rapporteur.
Washington, DC : The National Academies Press, [2017]

Keeping America's families safe : reforming the food safety system : hearing of the Committee on Hea

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
Washington : U.S. G.P.O., 2011.

Keeping America's families safe : reforming the food safety system : hearing of the Committee on Hea

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
Washington : U.S. G.P.O., 2011.

The mirage of safety : food additives and Federal policy

Hunter, Beatrice Trum.
New York : Scribner, [1975]

Overdose : how excessive government regulation stifles pharmaceutical innovation

Epstein, Richard Allen, 1943-
New Haven : Yale University Press, [2006]

Oversight of the Food and Drug Administration's progress in reducing unnecessary paperwork burdens u

United States. Congress. House. Committee on Small Business. Subcommittee on Government Programs.
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1996 [that is, 1997]

Personalized medicine and the FDA's emerging role

New York : Novinka, [2014]

Prescription drugs and the DEA : interactions and issues with controlled substances registrants

New York : Nova Publishers, 2016.

Protecting America's health : the FDA, business, and one hundred years of regulation

Hilts, Philip J.
New York : Alfred A. Knopf, 2003.

Public health effectiveness of the FDA 510(k) clearance process : balancing patient safety and innov

Washington, D.C. : National Academies Press, [2010]

Punitive damages : tort reform and FDA defenses : hearings before the Committee on the Judiciary, Un

United States. Congress. Senate. Committee on the Judiciary.
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1996.

Reforming Federal drug regulation : a round table held on February 23, 1976, and sponsored by the Ce

Washington : The Institute, [1976]

The regulation of pharmaceuticals : balancing the benefits and risks

Grabowski, Henry G.
Washington : American Enterprise Institute for Public Policy Research, [1983]

Reinventing regulation of drugs and medical devices

Clinton, Bill, 1946-
[Washington, D.C.?] : National Performance Review, [1995]

Reputation and power : organizational image and pharmaceutical regulation at the FDA

Carpenter, Daniel P., 1967- author.
Princeton : Princeton University Press, [2010]

Restoring FDA's ability to keep America's families safe : hearing of the Committee on Health, Educat

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
Washington : U.S. G.P.O., 2009.

Restoring FDA's ability to keep America's families safe : hearing of the Committee on Health, Educat

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
Washington : U.S. G.P.O., 2009.

Revitalizing new product development from clinical trials through FDA review : hearing of the Commit

United States. Congress. Senate. Committee on Labor and Human Resources.
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1996.

A risk-characterization framework for decision-making at the Food and Drug Administration

National Academies (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, author.
Washington D.C. : National Academies Press, [2011]

The risks of prescription drugs

New York : Columbia University Press, [2010]

The risks of prescription drugs

New York : Columbia University Press, [2010]

Role of commissioner of food and drugs : hearing before the Committee on Labor and Human Resources,

United States. Congress. Senate. Committee on Labor and Human Resources.
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1992.

Safety first : protecting America's food supply.

[Rockville, MD] : [Dept. of Health and Human Services, Public Health Service, Food and Drug Administration], [1988]

Seafood safety and adulterated products : FDA oversight & protection efforts

Hauppauge, N.Y. : Nova Science ; Lancaster : Gazelle [distributor], ©2012.

Strategy and science at the FDA : plans, goals and challenges for the future

Hauppauge, N.Y. : Nova Science Publishers, ©2012.

Strengthening a workforce for innovative regulatory science in therapeutics development : workshop s

Washington, D.C. : National Academies Press, [2012]